Drug Repositioning Through Network Pharmacology.

Area of Science:

• Pharmacology
• Systems Biology
• Drug Discovery

Background:

• Low drug productivity is a persistent challenge in the pharmaceutical industry.
• The traditional "single drug, single target, single disease" model limits therapeutic innovation.
• Network pharmacology provides a complementary approach from a systems biology perspective.

Purpose of the Study:

• To review the progress and prospects of network pharmacology in drug discovery.
• To highlight network pharmacology's role in addressing limitations of traditional pharmacologic dogma.
• To explore applications in drug repositioning and understanding drug-target-disease relationships.

Main Methods:

• Adopting a systems biology viewpoint to understand disease networks.
• Designing drugs to interact with multiple targets for network modulation.
• Utilizing network pharmacology for drug repositioning strategies.

Main Results:

• Network pharmacology enables modulation of disease networks towards normal status.
• It facilitates the discovery of drug off-targets and identification of disease-associated proteins.
• Pathway analysis elucidates complex relationships between drug targets and disease proteins.

Conclusions:

• Network pharmacology represents a significant advancement in drug discovery and development.
• This approach can enhance therapeutic efficacy by considering multi-target interactions.
• Future prospects include refining methods for target identification and pathway analysis.